Task: Answer Verification
Input (English): Question: Does heterologous expression of mutated HLA-G1 reduce alloreactivity of human dermal fibroblasts?
Answer: We are the first to successfully create a human fibroblast source with reduced alloreactivity using a novel mHLA-G1 construct. This approach may be extended to other cell types including human embryonic stem cells for use in allogeneic transplantation for cell-based regenerative medicine applications.
Output (English): yes